Assessment of the translational value of mouse lupus models using clinically relevant biomarkers

Translational Research

Volumn 163, Issue 6, 2014, Pages 515-532

  Bender, Andrew T ^a   Wu, Yin ^a   Cao, Qiongfang ^a   Ding, Yueyun ^a   Oestreicher, Judith ^a   Genest, Melinda ^a   Akare, Sandeep ^a   Ishizaka, Sally T ^a   Mackey, Matthew F ^a  

^a EISAI INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA INTERFERON; AUTOANTIBODY; BIOLOGICAL MARKER; CREATININE; GELATINASE B; PRISTANE;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTHRITIS; ARTICLE; BASEMENT MEMBRANE; CHROMATIN; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLOMERULUS FILTRATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; KAPLAN MEIER METHOD; KIDNEY INJURY; LUPUS ERYTHEMATOSUS NEPHRITIS; LUPUS VULGARIS; MOUSE; NEPHRITIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEINURIA; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSLATIONAL RESEARCH; UPREGULATION; UREA NITROGEN BLOOD LEVEL;

ANIMALS; ARTHRITIS, EXPERIMENTAL; AUTOANTIBODIES; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INTERFERONS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; MICE, INBRED NZB; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SPECIES SPECIFICITY; TERPENES; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84901194097     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2014.01.003     Document Type: Article

References (45)

1. Z. Liu, and A. Davidson Taming lupus: a new understanding of pathogenesis is leading to clinical advances Nat Med 18 2012 871 882
2. I.T. Harley, K.M. Kaufman, C.D. Langefeld, J.B. Harley, and J.A. Kelly Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies Nat Rev Genet 10 2009 285 290
3. N. Almqvist, T.H. Winkler, and I.L. Martensson Autoantibodies: focus on anti-DNA antibodies Self/Nonself 2 2011 11 18
4. R. Lu, J.M. Robertson, and B.F. Bruner et al. Multiple autoantibodies display association with lymphopenia, proteinuria, and cellular casts in a large, ethnically diverse SLE patient cohort Autoimmune Dis 2012 2012 819634
5. D. Perry, A. Sang, Y. Yin, Y.Y. Zheng, and L. Morel Murine models of systemic lupus erythematosus J Biomed Biotechnol 2011 2011 271694
6. L. Morel, and E.K. Wakeland Susceptibility to lupus nephritis in the NZB/W model system Curr Opin Immunol 10 1998 718 725
7. M. Satoh, A. Kumar, Y.S. Kanwar, and W.H. Reeves Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane Proc Natl Acad Sci U S A 92 1995 10934 10938
8. M. Satoh, H.B. Richards, and V.M. Shaheen et al. Widespread susceptibility among inbred mouse strains to the induction of lupus autoantibodies by pristane Clin Exp Immunol 121 2000 399 405
9. M.C. Gelfand, A.D. Steinberg, R. Nagle, and J.H. Knepshield Therapeutic studies in NZB-W mice: I. Synergy of azathioprine, cyclophosphamide and methylprednisolone in combination Arthritis Rheum 15 1972 239 246
10. Q.Z. Li, J. Zhou, and A.E. Wandstrat et al. Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes Clin Exp Immunol 147 2007 60 70
11. R.O. Williams Collagen-induced arthritis as a model for rheumatoid arthritis Methods Mol Med 98 2004 207 216
12. S. Gross, S.T. Gammon, and B.L. Moss et al. Bioluminescence imaging of myeloperoxidase activity in vivo Nat Med 15 2009 455 461
13. S. Yung, and T.M. Chan Anti-DNA antibodies in the pathogenesis of lupus nephritis: the emerging mechanisms Autoimmun Rev 7 2008 317 321
14. W.H. Reeves, P.Y. Lee, J.S. Weinstein, M. Satoh, and L. Lu Induction of autoimmunity by pristane and other naturally occurring hydrocarbons Trends Immunol 30 2009 455 464
15. H. Yoshida, M. Satoh, and K.M. Behney et al. Effect of an exogenous trigger on the pathogenesis of lupus in (NZB × NZW)F1 mice Arthritis Rheum 46 2002 2235 2244
16. C. Molino, F. Fabbian, and C. Longhini Clinical approach to lupus nephritis: recent advances Eur J Intern Med 20 2009 447 453
17. J.J. Weening, V.D. D'Agati, and M.M. Schwartz et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited J Am Soc Nephrol 15 2004 241 250
18. C. Xie, X.J. Zhou, X. Liu, and C. Mohan Enhanced susceptibility to end-organ disease in the lupus-facilitating NZW mouse strain Arthritis Rheum 48 2003 1080 1092
19. C. Patten, K. Bush, and I. Rioja et al. Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology Arthritis Rheum 50 2004 3334 3345
20. H.L. Wright, R.J. Moots, R.C. Bucknall, and S.W. Edwards Neutrophil function in inflammation and inflammatory diseases Rheumatology 49 2010 1618 1631
21. T.P. Karageorgas, D.D. Tseronis, and C.P. Mavragani Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes J Biomed Biotechnol 2011 2011 273907
22. Q.Z. Li, J. Zhou, and Y. Lian et al. Interferon signature gene expression is correlated with autoantibody profiles in patients with incomplete lupus syndromes Clin Exp Immunol 159 2010 281 291
23. Y. Yao, B.W. Higgs, L. Richman, B. White, and B. Jallal Use of type I interferon-inducible mRNAs as pharmacodynamic markers and potential diagnostic markers in trials with sifalimumab, an anti-IFNalpha antibody, in systemic lupus erythematosus Arthritis Res Ther 12 2010 S6
24. J.M. McBride, J. Jiang, and A.R. Abbas et al. Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: results of a phase I, placebo-controlled, double-blind, dose-escalation study Arthritis Rheum 64 2012 3666 3676
25. P.Y. Lee, Y. Kumagai, and Y. Li et al. TLR7-dependent and FcgammaR-independent production of type I interferon in experimental mouse lupus J Exp Med 205 2008 2995 3006
26. D.C. Nacionales, K.M. Kelly-Scumpia, and P.Y. Lee et al. Deficiency of the type I interferon receptor protects mice from experimental lupus Arthritis Rheum 56 2007 3770 3783
27. D. Arasappan, W. Tong, P. Mummaneni, H. Fang, and S. Amur Meta-analysis of microarray data using a pathway-based approach identifies a 37-gene expression signature for systemic lupus erythematosus in human peripheral blood mononuclear cells BMC Med 9 2011 65
28. A. Sang, Y. Yin, Y.Y. Zheng, and L. Morel Animal models of molecular pathology systemic lupus erythematosus Prog Mol Biol Transl Sci 105 2012 321 370
29. A. Davidson, and C. Aranow Lupus nephritis: lessons from murine models Nat Rev Rheumatol 6 2010 13 20
30. D.A. Isenberg, J.J. Manson, M.R. Ehrenstein, and A. Rahman Fifty years of anti-dsDNA antibodies: are we approaching journey's end? Rheumatology 46 2007 1052 1056
31. I. Balboni, S.M. Chan, M. Kattah, J.D. Tenenbaum, A.J. Butte, and P.J. Utz Multiplexed protein array platforms for analysis of autoimmune diseases Annu Rev Immunol 24 2006 391 418
32. K.H. Ching, P.D. Burbelo, and C. Tipton et al. Two major autoantibody clusters in systemic lupus erythematosus PLoS One 7 2012 e32001
33. T.B. Niewold, J.A. Kelly, and S.N. Kariuki et al. IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus Ann Rheum Dis 71 2012 463 468
34. L. Li, S. Nukala, and Y. Du et al. Murine lupus strains differentially model unique facets of human lupus serology Clin Exp Immunol 168 2012 178 185
35. D.L. Thibault, K.L. Graham, L.Y. Lee, I. Balboni, P.J. Hertzog, and P.J. Utz Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus Arthritis Res Ther 11 2009 R112
36. E. Savarese, C. Steinberg, and R.D. Pawar et al. Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis Arthritis Rheum 58 2008 1107 1115
37. E.S. Mortensen, and O.P. Rekvig Nephritogenic potential of anti-DNA antibodies against necrotic nucleosomes J Am Soc Nephrol 20 2009 696 704
38. P.H. Wooley, J.R. Seibold, J.D. Whalen, and J.M. Chapdelaine Pristane-induced arthritis: the immunologic and genetic features of an experimental murine model of autoimmune disease Arthritis Rheum 32 1989 1022 1030
39. M. Petri Review of classification criteria for systemic lupus erythematosus Rheum Dis Clin North Am 31 2005 245 254
40. G. Ruiz-Irastorza, M.A. Khamashta, G. Castellino, and G.R. Hughes Systemic lupus erythematosus Lancet 357 2001 1027 1032
41. M.C. Dall'era, P.M. Cardarelli, B.T. Preston, A. Witte, and J.C. Davis Jr. Type I interferon correlates with serological and clinical manifestations of SLE Ann Rheum Dis 64 2005 1692 1697
42. C.E. Weckerle, B.S. Franek, and J.A. Kelly et al. Network analysis of associations between serum interferon-alpha activity, autoantibodies, and clinical features in systemic lupus erythematosus Arthritis Rheum 63 2011 1044 1053
43. G. Obermoser, and V. Pascual The interferon-alpha signature of systemic lupus erythematosus Lupus 19 2010 1012 1019
44. D.L. Sim, H. Bagavant, and Y.M. Scindia et al. Genetic complementation results in augmented autoantibody responses to lupus-associated antigens J Immunol 183 2009 3505 3511
45. U. Sriram, L. Varghese, and H.L. Bennett et al. Myeloid dendritic cells from B6.NZM Sle1/Sle2/Sle3 lupus-prone mice express an IFN signature that precedes disease onset J Immunol 189 2012 80 91